Stability Indicating Method Development and Validation for the Estimation of Bempedoic Acid and Ezetimibe by Reverse Phase– Ultra Performance Liquid Chromatography

Authors

  • Divya Molleti A.U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh, India
  • Krishnamanjari Pawar Amgoth A.U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh, India
  • Sushma Pallekona A.U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh, India

Abstract

A simple, accurate, precise method was developed to simultaneously estimate the bempedoic acid (BEM) and ezetimibe (EZT) in bulk and pharmaceutical dosage form using RP-UPLC. Combination of bempedoic acid and ezetimibe is used to treat adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease. Chromatographic separation was carried out using X-Bridge phenyl 150 x 4.6 mm, 3.5 μ column at a 1.0 mL/min flow rate. The mobile phase consisted of 0.1% formic acid buffer and acetonitrile (70:30%v/v). The retention times of BEM and EZT were found to be 1.157 and 3.208 minutes, respectively. The temperature was maintained at ambient. The optimized wavelength for BEM and EZT was 230 nm. The method developed has been statistically validated according to ICH guidelines. %RSD of BEM and EZT were and found to be 0.6 and 1.4, respectively. %Recovery was obtained as 100.0% and 101.40% for BEM and EZT, respectively. LoD, LoQ values were obtained from regression equations of Bempedoic acid and Eetimibe were 0.27 μg/mL, 0.015 μg/mL and 2.7 μg/mL, 0.15 μg/mL respectively. The method obeys Beer’s law in the concentration range of 27–337.5 μg/mL (R2 = 0.9991) for BEM, and 1.5–18.75 μg/mL (R2 = 0.9993) for EZT. The method showed good reproducibility and recovery with %RSD less than 2. Forced degradation studies established the stability-indicating capability of the method under stress conditions like acid, base, peroxide, UV, thermal, humidity. Retention times were decreased and that run time was decreased. Hence, the chromatographic method developed was simple and economical and can be adopted in regular quality control test in Industries. It is said to be rapid, specific, sensitive, robust, and reliable and can be effectively applied for routine analysis in research institutions, quality control departments in industries.

Keywords:

Bempedoic acid and ezetimibe, forced degradation, RP-UPLC

DOI

https://doi.org/10.25004/IJPSDR.2021.130514

References

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid =88d06d89-a3da-40b4-b273-8f4f7d56c4c9.

https://esperion.com/science/bempedoic-acid/ “Veramyst”. Drugs. com. 21 June 2019. Retrieved 4 February 2020.

https://go.drugbank.com/drugs/DB11936.

https://en.wikipedia.org/wiki/Ezetimibe

https://go.drugbank.com/drugs/DB00973

https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/ 021445s019lbl.pdf

Goel A, Baboota S, Sahni JK, Srinivas KS, Gupta RS, Gupta A, Semwal VP, Ali J. Development and validation of stability-indicating assay method by UPLC for a fixed dose combination of atorvastatin and ezetimibe. Journal of chromatographic science. 2013 Mar 1;51(3):222-228. https://doi.org/10.1093/chromsci/bms131.

Trefi S. Simultaneous assessment of atorvastatin-ezetimibe com¬bination in tablets by an ion-pair RP-HPLC. Research Journal of Pharmacy and Technology. 2020;13(9):4195-4199. doi: 10.5958/ 0974-360X.2020.00741.6

Shah U, Kunti S, Rupal Patel. Stability-indicating Analytical Method Development using Quality by Design Approach for Simultaneous Estimation of Ezetimibe and Glimepiride. Indian J Pharm Sci, 2019; 81(2):273-281. doi: 10.36468/pharmaceutical-sciences.508.

Praveen K, Vidyadhara S, Murthy T.E.G.K., Venkateswara Rao B, Nikhila V. A novel reverse phase liquid chromatographic method development and validation for the simultaneous estimation of atorvastatin, ezetimibe and fenofibrate in bulk and tablet dosage form. Int. J. Pharm. Sci. Res., 2016; 7(10): 4145-4151. doi: 10.13040/ IJPSR.0975-8232.7(10).4145-51.

Swetha Chandrika G. RP-HPLC Method Development and Validation for the Simultaneous Estimation of Atorvastatin, Fenofibrate and Ezetimibe in a Pharmaceutical Dosage Form. Anal. Biochem. 2015, 4:2. doi: 10.4172/2161-1009.1000177.

ICH Harmonised Tripartite Guideline: Validation of Analytical Procedures: Text and Methodology Q2 (R1), current Step 4 version; International Conference on Harmonization, 2005.

ICH Harmonised Tripartite Guideline: Stability Testing of New Drug Substances and Products Q1A (R2), current Step 4 version; International Conference on Harmonization, 2003.

Published

30-09-2021
Statistics
Abstract Display: 1286
PDF Downloads: 1275
Dimension Badge

How to Cite

“Stability Indicating Method Development and Validation for the Estimation of Bempedoic Acid and Ezetimibe by Reverse Phase– Ultra Performance Liquid Chromatography”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 13, no. 5, Sept. 2021, pp. 559-64, https://doi.org/10.25004/IJPSDR.2021.130514.

Issue

Section

Research Article

How to Cite

“Stability Indicating Method Development and Validation for the Estimation of Bempedoic Acid and Ezetimibe by Reverse Phase– Ultra Performance Liquid Chromatography”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 13, no. 5, Sept. 2021, pp. 559-64, https://doi.org/10.25004/IJPSDR.2021.130514.

Similar Articles

1-10 of 302

You may also start an advanced similarity search for this article.